Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD).
Santasusana JM, García López JL, García JJ, Carbonero AI, Plazas JG, Rovira PS, Martos CF, Guzmán MC, Jericó JF, Delgado FJ, Espinosa JC, Muñoz ML, Aguilar EA, Valera JS, García Ribas I, Mena AC. Santasusana JM, et al. Among authors: aguilar ea. Clin Transl Oncol. 2005 Dec;7(11):493-8. doi: 10.1007/BF02717002. Clin Transl Oncol. 2005. PMID: 16373060 Clinical Trial.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
PETACC-8 study investigators; Thaler J, Greil R, Gaenzer J, Eisterer W, Tschmelitsch J, Samonigg H, Zabernigg A, Schmid F, Steger G, Steinacher R, Andel J, Lang A, Függer R, Hofbauer F, Woell E, Geissler D, Lenauer A, Prager M, Van Laethem JL, Van Cutsem E, D'Haens G, Demolin G, Kerger J, Deboever G, Ghillebert G, Polus M, Van Cutsem E, RezaieKalantari H, Delaunoit T, Goeminne JC, Peeters M, Vergauwe P, Houbiers G, Humblet Y, Janssens J, Schrijvers D, Vanderstraeten E, Van Laethem JL, Vermorken J, Van Daele D, Ferrante M, Forget F, Hendlisz A, Yilmaz M, Nielsen SE, Vestermark L, Larsen J, Ychou M, Zawadi A, Zawadi MA, Bouche O, Mineur L, Bennouna-Louridi J, Dourthe LM, Ychou M, Boucher E, Taieb J, Pezet D, Desseigne F, Ducreux M, Texereau P, Miglianico L, Rougier P, Fratte S, Levache CB, Merrouche Y, Ellis S, Locher C, Ramee JF, Garnier C, Viret F, Chauffert B, Cojean-Zelek I, Michel P, Lecaille C, Borel C, Seitz JF, Smith D, Lombard-Bohas C, Andre T, Gornet JM, Fein F, Coulon-Sfairi MA, Kaminsky MC, Lagasse JP, Luet D, Etienne PL, Gasmi M, Vanoli A, Nguyen S, Aparicio T, Perrier H, Stremsdoerfer N, Laplaige P, Arsene D, Auby D, Bedenne L, Coriat R, Denis B, Geoffroy P, Piot G, Be… See abstract for full author list ➔ PETACC-8 study investigators, et al. Among authors: aguilar ea. Ann Oncol. 2015 Apr;26(4):822-825. doi: 10.1093/annonc/mdv070. Ann Oncol. 2015. PMID: 25814651 Free article. No abstract available.
Primary oat cell carcinoma of the larynx.
Aguilar EA 3rd, Robbins KT, Stephens J, Dimery IW, Batsakis JG. Aguilar EA 3rd, et al. Am J Clin Oncol. 1987 Feb;10(1):26-32. doi: 10.1097/00000421-198702000-00006. Am J Clin Oncol. 1987. PMID: 3030091
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study.
Sastre J, García-Alfonso P, Viéitez JM, Cano MT, Rivera F, Reina-Zoilo JJ, Salud-Salvia A, Quintero G, Robles-Díaz L, Safont MJ, La Casta A, Gil S, Polo E, Asensio-Martínez E, García-Paredes B, López RL, Guillot M, Valladares-Ayerbes M, Aranda E, Díaz-Rubio E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). Sastre J, et al. ESMO Open. 2021 Apr;6(2):100062. doi: 10.1016/j.esmoop.2021.100062. Epub 2021 Mar 10. ESMO Open. 2021. PMID: 33711671 Free PMC article. Clinical Trial.
Surgical treatment of pulmonary metastases: experience with 40 patients.
de la Haba Rodríguez JR, Algar Algar J, Méndez Vidal MJ, Aranda IB, Alvarez Kindelan A, López Pujol J, Aguilar EA. de la Haba Rodríguez JR, et al. Among authors: aguilar ea. Eur J Surg Oncol. 2002 Feb;28(1):49-54. doi: 10.1053/ejso.2001.1068. Eur J Surg Oncol. 2002. PMID: 11869014
Breast cancer screening: another point of view.
de la Haba Rodríguez JR, Chamorro RM, Vidal MJ, Blanch RS, Beltrán LT, Benito MA, Cabezas SG, Carrasco AJ, Aguilar EA. de la Haba Rodríguez JR, et al. Among authors: aguilar ea. Eur J Cancer Prev. 2005 Feb;14(1):1-5. doi: 10.1097/00008469-200502000-00001. Eur J Cancer Prev. 2005. PMID: 15677889
257 results